Pharmacogenomics

Heat shock protein - receptor-based pharmacogenomics: the search for new cancer antigens
pp. 117-120(4)
Authors: Stebbing, Justin; Srivastava, Pramod

Nutrigenomics and the prevention of colon cancer
pp. 121-124(4)
Author: Davis, Cindy D

Unraveling hypertension: epigenomics comes of age
pp. 125-128(4)
Author: Fornage, Myriam

Gene-expression profiling in lung cancer: still early days
pp. 129-132(4)
Authors: Yang, Ping; Sun, Zhifu

Silent mutations: not so quiet?
pp. 133-135(3)

The diverse and informative future of microarray applications
pp. 137-140(4)
Author: Putonti, Catherine

Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in methotrexate-treated rheumatoid arthritis patients
pp. 141-150(10)
Authors: van der Straaten, RJHM; Wessels, Judith AM; de Vries-Bouwstra, Jeska K; Goekoop-Ruiterman, Yvonne PM; Allaart, Cornelia F; Bogaartz, Judith; Tiller, Marco; Huizinga, Tom WJ; Guchelaar, Henk-Jan

CYP2A6 polymorphisms: is there a role for pharmacogenomics in preventing coumarin-induced hepatotoxicity in lymphedema patients?
pp. 151-158(8)
Authors: Farinola, Nicholas; Piller, Neil B

Pharmacogenetics of antiparkinsonian drug treatment: a systematic review
pp. 159-176(18)
Authors: Arbouw, Maurits EL; van Vugt, Jeroen PP; Egberts, Toine CG; Guchelaar, Henk-Jan

Mapping translational research in personalized therapeutics: from molecular markers to health policy
pp. 177-185(9)
Authors: Ozdemir, Vural; Williams-Jones, Bryn; Cooper, Dan M; Someya, Toshiyuki; Godard, Béatrice

CYP2C8 and antimalaria drug efficacy
pp. 187-198(12)
Authors: Gil, JP; Gil Berglund, E

Comparison of HapMap data on Affymetrix and Illumina platforms: expanding the power of studies and a not so unexpected synergy
pp. 199-201(3)
Author: Dobrin, Seth